BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27423467)

  • 1. Suppressor of cytokine signaling (SOCS) proteins are induced by IL-7 and target surface CD127 protein for degradation in human CD8 T cells.
    Ghazawi FM; Faller EM; Parmar P; El-Salfiti A; MacPherson PA
    Cell Immunol; 2016; 306-307():41-52. PubMed ID: 27423467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-7 induces clathrin-mediated endocytosis of CD127 and subsequent degradation by the proteasome in primary human CD8 T cells.
    Faller EM; Ghazawi FM; Cavar M; MacPherson PA
    Immunol Cell Biol; 2016 Feb; 94(2):196-207. PubMed ID: 26272555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 tat protein recruits CIS to the cytoplasmic tail of CD127 to induce receptor ubiquitination and proteasomal degradation.
    Sugden S; Ghazawi F; MacPherson P
    Virology; 2016 Nov; 498():192-200. PubMed ID: 27596538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-7 and the HIV Tat protein act synergistically to down-regulate CD127 expression on CD8 T cells.
    Faller E; Kakal J; Kumar R; Macpherson P
    Int Immunol; 2009 Mar; 21(3):203-16. PubMed ID: 19147839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-7 downregulates IL-7Rα expression in human CD8 T cells by two independent mechanisms.
    Ghazawi FM; Faller EM; Sugden SM; Kakal JA; MacPherson PA
    Immunol Cell Biol; 2013 Feb; 91(2):149-58. PubMed ID: 23207282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-7 induces sCD127 release and mCD127 downregulation in human CD8
    Côté SC; Burke Schinkel SC; Berthoud TK; Barros PO; Sanchez-Vidales M; Davidson AM; Crawley AM; Angel JB
    Eur J Immunol; 2020 Oct; 50(10):1537-1549. PubMed ID: 32390135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-7-dependent STAT-5 activation and CD8+ T cell proliferation are impaired in HIV infection.
    Vranjkovic A; Crawley AM; Patey A; Angel JB
    J Leukoc Biol; 2011 Apr; 89(4):499-506. PubMed ID: 21177484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-4 downregulates CD127 expression and activity on human thymocytes and mature CD8+ T cells.
    Crawley AM; Vranjkovic A; Young C; Angel JB
    Eur J Immunol; 2010 May; 40(5):1396-407. PubMed ID: 20201040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
    Lejeune D; Demoulin JB; Renauld JC
    Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-bet-mediated differentiation of the activated CD8+ T cell.
    Yeo CJ; Fearon DT
    Eur J Immunol; 2011 Jan; 41(1):60-6. PubMed ID: 21182077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of IL-21 signaling by suppressor of cytokine signaling-1 (SOCS1) in CD8(+) T lymphocytes.
    Gagnon J; Ramanathan S; Leblanc C; Ilangumaran S
    Cell Signal; 2007 Apr; 19(4):806-16. PubMed ID: 17126530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOCS proteins: negative regulators of cytokine signaling.
    Krebs DL; Hilton DJ
    Stem Cells; 2001; 19(5):378-87. PubMed ID: 11553846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble HIV Tat protein removes the IL-7 receptor alpha-chain from the surface of resting CD8 T cells and targets it for degradation.
    Faller EM; Sugden SM; McVey MJ; Kakal JA; MacPherson PA
    J Immunol; 2010 Sep; 185(5):2854-66. PubMed ID: 20660706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of the IL-7Rα gene by dexamethasone and IL-7 in primary human CD8 T cells.
    Kakal JA; Ghazawi FM; Faller EM; Sugden SM; Parmar P; MacPherson PA
    Immunogenetics; 2017 Jan; 69(1):13-27. PubMed ID: 27541597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-8 induces miR-424-5p expression and modulates SOCS2/STAT5 signaling pathway in oral squamous cell carcinoma.
    Peng HY; Jiang SS; Hsiao JR; Hsiao M; Hsu YM; Wu GH; Chang WM; Chang JY; Jin SL; Shiah SG
    Mol Oncol; 2016 Jun; 10(6):895-909. PubMed ID: 27038552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinase inhibition, competitive binding and proteasomal degradation: resolving the molecular function of the suppressor of cytokine signaling (SOCS) proteins.
    Linossi EM; Nicholson SE
    Immunol Rev; 2015 Jul; 266(1):123-33. PubMed ID: 26085211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric γc cytokine receptors confer cytokine independent engraftment of human T lymphocytes.
    Hunter MR; Prosser ME; Mahadev V; Wang X; Aguilar B; Brown CE; Forman SJ; Jensen MC
    Mol Immunol; 2013 Nov; 56(1-2):1-11. PubMed ID: 23628622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. m
    Li HB; Tong J; Zhu S; Batista PJ; Duffy EE; Zhao J; Bailis W; Cao G; Kroehling L; Chen Y; Wang G; Broughton JP; Chen YG; Kluger Y; Simon MD; Chang HY; Yin Z; Flavell RA
    Nature; 2017 Aug; 548(7667):338-342. PubMed ID: 28792938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOCS2 can enhance interleukin-2 (IL-2) and IL-3 signaling by accelerating SOCS3 degradation.
    Tannahill GM; Elliott J; Barry AC; Hibbert L; Cacalano NA; Johnston JA
    Mol Cell Biol; 2005 Oct; 25(20):9115-26. PubMed ID: 16199887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling.
    van de Geijn GJ; Gits J; Touw IP
    J Leukoc Biol; 2004 Jul; 76(1):237-44. PubMed ID: 15107455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.